Sanofi Consumer Healthcare India Limited has informed the Exchange regarding disclosure received from Opal Bidco SAS, in relation to acquisition of equity share of the Company pursuant to Open Offer under SEBI (SAST) Regulations, 2011
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Opal Bidco SAS, a member of the promoter group based in Paris, acquired 25,04,630 equity shares of Sanofi Consumer Healthcare India Limited, representing 10.87% of the company's total share capital, for a total consideration of approximately ₹1,247.82 crore. The acquisition was executed off-market on June 11, 2025, pursuant to an open offer triggered under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This open offer was triggered because Opal Bidco SAS indirectly acquired 100% of Opella Healthcare Participations BV, which already holds 1,39,09,587 equity shares (about 60.4%) in the company. The disclosure was filed under the SEBI Insider Trading Regulations and received by the company on June 12, 2025.
For shareholders, this confirms that the promoter group's stake in Sanofi Consumer Healthcare India has increased further through the open offer process, consolidating control. The stock may see reduced trading liquidity post-open offer, and minority shareholders had an opportunity to tender shares at the open offer price.